Sagespring Wealth Partners LLC Invests $8.86 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Sagespring Wealth Partners LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 17,514 shares of the healthcare conglomerate's stock, valued at approximately $8,860,000.

Several other institutional investors have also modified their holdings of the business. NewSquare Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth about $25,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $28,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group in the fourth quarter worth approximately $30,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $32,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH traded down $3.63 during mid-day trading on Tuesday, hitting $583.43. The company's stock had a trading volume of 3,865,335 shares, compared to its average volume of 4,340,638. The firm has a 50-day simple moving average of $513.80 and a 200 day simple moving average of $541.83. The firm has a market capitalization of $533.67 billion, a P/E ratio of 37.64, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $438.50 and a 1-year high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the business earned $5.83 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.44%. UnitedHealth Group's payout ratio is 54.19%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on UNH shares. Mizuho upped their price objective on UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a report on Friday, January 17th. Finally, Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Twenty-one analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has an average rating of "Buy" and a consensus price target of $632.85.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.